ADBiotech Co., Ltd. (KOSDAQ:179530)
3,830.00
+30.00 (0.79%)
At close: Oct 2, 2025
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 41.20 billion as of October 10, 2025. Its market cap has increased by 22.47% in one year.
Market Cap
41.20B
Enterprise Value
53.15B
Revenue
12.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,830.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 41.20B, an increase of 62.54%. That is a compound annual growth rate of 8.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 2, 2025 | 48.47B | 154.96% |
Dec 30, 2024 | 19.01B | -36.49% |
Dec 28, 2023 | 29.93B | -2.53% |
Dec 29, 2022 | 30.71B | -31.89% |
Dec 30, 2021 | 45.09B | 20.26% |
Dec 30, 2020 | 37.49B | 47.46% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 579.68T |
SK hynix | 273.06T |
LG Energy Solution | 93.37T |
Samsung Biologics | 71.81T |
Hanwha Aerospace | 56.44T |
Hyundai Motor Company | 48.05T |
HD Hyundai Heavy Industries | 46.87T |
KB Financial Group | 42.53T |